Key result
SVM classifier achieves ~83% fault detection accuracy in lithium-ion batteries using limited current sensors.
Why the study?
Safety concerns, especially fires caused by cell faults, affect battery pack uptake, requiring advances in battery management systems to mitigate fault risks.
Absolute Event Rate: 83% vs 47%
A support vector machine classifier can accurately detect faulty lithium-ion cells in large parallel battery packs using current information from a limited number of cells, potentially improving battery management systems.
Enables reduced monitoring in large battery packs; leaves open prospective validation before safety-critical adoption.
One of the main concerns affecting the uptake of battery packs is safety, particularly with respect to fires caused by cell faults. Mitigating possible risks from faults requires advances in battery management systems and an understanding of the dynamics of large packs. To address this, a machine learning classifier based upon a support vector machine was developed that detects cell faults within large packs using a limited number of current sensors. To train the classifier, a modelling framework for parallel-connected packs is introduced and shown to generalise to Doyle-Fuller-Newman electrochemical models. The fault classification performance was found to be satisfactory, with an accuracy of 83% using current information from only 27% of the cells. Validation on experimental pack data is also shown. These results highlight the potential to combine mathematical modelling and machine learning to improve battery management systems and deal with the complexities of large packs.
No takes yet. Share an insight, caveat, or question.
Lambert et al. (2026) studied Lithium-ion battery faults. Support vector machine (SVM) classifier vs. Recurrent neural network (RNN) was evaluated on Fault classification accuracy. A support vector machine classifier detected cell faults within large parallel lithium-ion battery packs with an accuracy of 83% using current information from only 27% of the cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: